These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
414 related articles for article (PubMed ID: 33095835)
21. [Diabetes and hypertension as factors associated with Covid-19 lethality in Sonora, Mexico, 2020]. Álvarez-López DI; Espinoza-Molina MP; Cruz-Loustaunau ID; Álvarez-Hernández G Salud Publica Mex; 2020; 62(5):456-457. PubMed ID: 33027852 [No Abstract] [Full Text] [Related]
22. Prevalence and Associated Risk Factors of Mortality Among COVID-19 Patients: A Meta-Analysis. Noor FM; Islam MM J Community Health; 2020 Dec; 45(6):1270-1282. PubMed ID: 32918645 [TBL] [Abstract][Full Text] [Related]
23. Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis. Kumar A; Arora A; Sharma P; Anikhindi SA; Bansal N; Singla V; Khare S; Srivastava A Diabetes Metab Syndr; 2020; 14(4):535-545. PubMed ID: 32408118 [TBL] [Abstract][Full Text] [Related]
24. Comorbid diabetes and the risk of disease severity or death among 8807 COVID-19 patients in China: A meta-analysis. Guo L; Shi Z; Zhang Y; Wang C; Do Vale Moreira NC; Zuo H; Hussain A Diabetes Res Clin Pract; 2020 Aug; 166():108346. PubMed ID: 32710998 [TBL] [Abstract][Full Text] [Related]
25. Diabetes in COVID-19: Prevalence, pathophysiology, prognosis and practical considerations. Singh AK; Gupta R; Ghosh A; Misra A Diabetes Metab Syndr; 2020; 14(4):303-310. PubMed ID: 32298981 [TBL] [Abstract][Full Text] [Related]
26. Diabetes and covid-19: more than the sum of two morbidities. Pititto BA; Ferreira SRG Rev Saude Publica; 2020; 54():54. PubMed ID: 32491053 [TBL] [Abstract][Full Text] [Related]
27. Clinical characteristics and risk factors for mortality of patients with COVID-19 in a large data set from Mexico. Parra-Bracamonte GM; Lopez-Villalobos N; Parra-Bracamonte FE Ann Epidemiol; 2020 Dec; 52():93-98.e2. PubMed ID: 32798701 [TBL] [Abstract][Full Text] [Related]
28. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis. Yang J; Zheng Y; Gou X; Pu K; Chen Z; Guo Q; Ji R; Wang H; Wang Y; Zhou Y Int J Infect Dis; 2020 May; 94():91-95. PubMed ID: 32173574 [TBL] [Abstract][Full Text] [Related]
29. The Effect of Coronavirus Disease 2019 on Cardiovascular Diseases. Askin L; Tanrıverdi O; Askin HS Arq Bras Cardiol; 2020 Jun; 114(5):817-822. PubMed ID: 32491073 [TBL] [Abstract][Full Text] [Related]
30. Characteristics and outcomes of diabetic patients infected by the SARS-CoV-2. Elamari S; Motaib I; Zbiri S; Elaidaoui K; Chadli A; Elkettani C Pan Afr Med J; 2020; 37():32. PubMed ID: 33209159 [TBL] [Abstract][Full Text] [Related]
31. Comorbidities and the risk of severe or fatal outcomes associated with coronavirus disease 2019: A systematic review and meta-analysis. Zhou Y; Yang Q; Chi J; Dong B; Lv W; Shen L; Wang Y Int J Infect Dis; 2020 Oct; 99():47-56. PubMed ID: 32721533 [TBL] [Abstract][Full Text] [Related]
32. Adaptation of a Russian population to SARS-CoV-2: Asymptomatic course, comorbidities, mortality, and other respiratory viruses - A reply to Fear versus Data. Sharov KS Int J Antimicrob Agents; 2020 Oct; 56(4):106093. PubMed ID: 32653618 [TBL] [Abstract][Full Text] [Related]
33. Association of diabetes and hypertension with disease severity in covid-19 patients: A systematic literature review and exploratory meta-analysis. Parveen R; Sehar N; Bajpai R; Agarwal NB Diabetes Res Clin Pract; 2020 Aug; 166():108295. PubMed ID: 32623032 [TBL] [Abstract][Full Text] [Related]
34. Prevalence of comorbidities in patients and mortality cases affected by SARS-CoV2: a systematic review and meta-analysis. Espinosa OA; Zanetti ADS; Antunes EF; Longhi FG; Matos TA; Battaglini PF Rev Inst Med Trop Sao Paulo; 2020; 62():e43. PubMed ID: 32578683 [TBL] [Abstract][Full Text] [Related]
35. Diabetes mellitus increases the risk of hospital mortality in patients with Covid-19: Systematic review with meta-analysis. Miller LE; Bhattacharyya R; Miller AL Medicine (Baltimore); 2020 Oct; 99(40):e22439. PubMed ID: 33019426 [TBL] [Abstract][Full Text] [Related]
36. Case fatality of COVID-19 in patients with neurodegenerative dementia. Reyes-Bueno JA; Mena-Vázquez N; Ojea-Ortega T; Gonzalez-Sotomayor MM; Cabezudo-Garcia P; Ciano-Petersen NL; Pons-Pons G; Castro-Sánchez MV; Serrano-Castro PJ Neurologia (Engl Ed); 2020; 35(9):639-645. PubMed ID: 32893069 [TBL] [Abstract][Full Text] [Related]
37. Implications of COVID-19 in high burden countries for HIV/TB: A systematic review of evidence. Tamuzi JL; Ayele BT; Shumba CS; Adetokunboh OO; Uwimana-Nicol J; Haile ZT; Inugu J; Nyasulu PS BMC Infect Dis; 2020 Oct; 20(1):744. PubMed ID: 33036570 [TBL] [Abstract][Full Text] [Related]
38. COVID-19, chronic inflammatory respiratory diseases and eosinophils-Observations from reported clinical case series. Jesenak M; Banovcin P; Diamant Z Allergy; 2020 Jul; 75(7):1819-1822. PubMed ID: 32369190 [No Abstract] [Full Text] [Related]
39. Prevalence and characterization of asthma in hospitalized and nonhospitalized patients with COVID-19. Chhiba KD; Patel GB; Vu THT; Chen MM; Guo A; Kudlaty E; Mai Q; Yeh C; Muhammad LN; Harris KE; Bochner BS; Grammer LC; Greenberger PA; Kalhan R; Kuang FL; Saltoun CA; Schleimer RP; Stevens WW; Peters AT J Allergy Clin Immunol; 2020 Aug; 146(2):307-314.e4. PubMed ID: 32554082 [TBL] [Abstract][Full Text] [Related]
40. Risk factors for the exacerbation of patients with 2019 Novel Coronavirus: A meta-analysis. Zhao J; Li X; Gao Y; Huang W Int J Med Sci; 2020; 17(12):1744-1750. PubMed ID: 32714077 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]